Latest Breaking News On - Synageva biopharma - Page 1 : vimarsana.com

PureTech Health plc: PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments

PureTech Health plc: PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomExperte carsten storkDenice torresZwei rohstoff chancenEric greenNichole bobbynRob winderSteve paulDaphne zoharEli lillyBen atwellSynageva biopharmaMichael chenSchool of engineeringHead of research

PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments

Denice Torres, J.D., former Board Member of Karuna Therapeutics and accomplished healthcare executive at Johnson & Johnson, Janssen Neuroscience and Eli Lilly, appointed to Seaport Board of.

United statesEric greenDenice torresSteve paulDaphne zoharSynageva biopharmaMichael chenEli lillyHead of development programs at alnylam pharmaceuticalsSloan school of managementDepartment of neurologyHealthcare businesswomen association woman of the yearAlnylam pharmaceuticalsStanford universityHarvard medical schoolBristol myers squibb

PRTC s Seaport Announces Board/Team Appointments | Company Announcement

PRTC s Seaport Announces Board/Team Appointments | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNichole bobbynEli lillySynageva biopharmaEric greenRob winderDaphne zoharSteve paulBen atwellDenice torresMichael chenHarvard medical schoolSloan school of managementDepartment of neurologySchool of engineering

Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani

CAMBRIDGE, Mass. (BUSINESS WIRE) Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the appointm.

United statesUnited kingdomAdicet bioJay backstromMo qatananiAmir nashatMolly macleodSynageva biopharmaRushmie nofsingerDavid hallalBaylor college of medicineInstitute for diabetesUniversity of californiaUniversity of pennsylvania school medicineExchange commissionCalifornia life sciences

Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph D to Chief Scientific Officer

Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph D to Chief Scientific Officer
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesMo qatananiAmir nashatSynageva biopharmaAdicet bioJay backstromDavid hallalRoche holdingAmerican university of beirutCalifornia life sciencesScholar rock incAmgen incUniversity of californiaInstitute for diabetesAlexion pharmaceuticalsBaylor college of medicine